Clinical development
- Sinovac Launches Groundbreaking Phase 3 Trial for First Global Multivalent HFMD Vaccine
16 Dec, 2024 - China’s mpox vaccine ready for clinical trial
16 Dec, 2024 - Mpox vaccine ready for clinical trial
14 Dec, 2024 - ‘Safety signal’ in Moderna’s RSV vaccine studies halts trials of other vaccines for childhood killer
13 Dec, 2024 - A flu-COVID combo vaccine just received fast-track designation. Here’s what to know
13 Dec, 2024 - Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in children aged 10–12 years: phase III randomized trial complementary analysis of immune persistence 3–6 years after priming
13 Dec, 2024 - Blue Lake Biotechnology sees success in early RSV vaccine results
12 Dec, 2024 - How BioNTech’s “revolutionary” lung cancer vaccine actually works
12 Dec, 2024 - PDC*line Pharma Presents Primary Clinical Results From Phase I/II Trial on PDC*lung01 Cancer Vaccine at ESMO-IO 2024
12 Dec, 2024 - SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
12 Dec, 2024 - Elicio reports promising cancer vaccine trial results
12 Dec, 2024 - Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
12 Dec, 2024 - The Christie: Bowel cancer vaccine trial ‘big advance’ – doctor
12 Dec, 2024 - New hepatitis B vaccine offers superior protection for people with HIV
12 Dec, 2024 - NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1: Press Releases
12 Dec, 2024 - OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®
11 Dec, 2024 - CORRECTING and REPLACING Publication in NPJ Vaccines Highlights Benefits of Stratis
11 Dec, 2024 - First vaccine against blood-stage malaria is well-tolerated and offers effective protection in clinical trial
11 Dec, 2024 - Updated Hep B Vaccine More Effective for People with HIV
11 Dec, 2024 - Sanofi’s flu-COVID combo vaccines gain FDA Fast Track designation
11 Dec, 2024 - Publication of clinical Phase IIb trial data for the adjuvanted RH5.1 blood-stage malaria vaccine
11 Dec, 2024 - Interim results of malaria vaccine Phase 2b trial show ‘promising efficacy’
11 Dec, 2024 - Breakthrough Malaria Vaccine Shows Promising Results in Trials
11 Dec, 2024 - New vaccine for disease that kills 608,000 people a year
11 Dec, 2024 - NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
11 Dec, 2024 - Phase 3 Trial Initiated for COVID-19-Influenza Combination and Stand-Alone Influenza
11 Dec, 2024 - International study shows updated hepatitis B vaccine more effective for people with HIV
10 Dec, 2024 - Data: Rotavirus vaccine benefits NICU babies, with disease spread rare
10 Dec, 2024 - Novavax Launches Phase 3 Trial for Revolutionary COVID-Flu Combo Vaccine in Elderly Population
10 Dec, 2024 - HepB-CpG Offers Superior Seroprotection in People with HIV, Prior HBV Vaccine Nonresponse
09 Dec, 2024
0 Comments